100
The global rheumatoid arthritis market is projected to grow significantly, with an expected CAGR of around 5.50% from 2022 to 2029. The market was valued at USD 45.6 billion in 2021 and is anticipated to reach USD 69.98 billion by 2029[1].
Key drivers of market growth include advancements in biologics, favorable reimbursement policies, and increasing healthcare expenditures. However, challenges such as high treatment costs and a lack of qualified healthcare personnel may impede market expansion[1].
Sign Up To Try Advanced Features
Get more accurate answers with Super Pandi, upload files, personalized discovery feed, save searches and contribute to the PandiPedia.
Sorry, Pandi could not find an answer.
Let's look at alternatives:
- Modify the query.
- Start a new thread.
- Remove sources (if manually added).
